In Vitro Pim Kinase Activity Assay

YS Yuichi Sawaguchi
RY Ryuta Yamazaki
YN Yukiko Nishiyama
MM Masayuki Mae
AA Atsuhiro Abe
HN Hiroyuki Nishiyama
FN Fukiko Nishisaka
TI Tatsuya Ibuki
TS Toshio Sasai
TM Takeshi Matsuzaki
ask Ask a question
Favorite

The inhibition ratios of test compounds for Pim-1, 2 (Life Technologies; Thermo Fisher Scientific Inc., MA, United States), 3 (Merck KgaA), and FLT3 (Life Technologies; Thermo Fisher Scientific Inc., MA, United States) were determined using a modified FRET-based Z′-LYTE kinase assay kit (Invitrogen; Thermo Fisher Scientific Inc.). The Ser/Thr 7 peptide and Tyr-2 peptide were used as substrates for Pim kinases and FLT3, respectively. The reactions were carried out in a 384-well plate with a 10 µL reaction volume per well containing 1 µM substrates in 50 mM HEPES buffer with pH 7.5, 0.01% BRIJ-35, 10 mM MgCl2, 1 mM EGTA, and an appropriate amount of kinases (Pim-1: 0.03 μg/ml, Pim-2: 0.2 μg/ml, Pim-3: 0.2 μg/ml, FLT3: 0.1 μg/ml) with test compounds. The final reaction concentrations of ATP were 400, 5, 100, and 500 µM for Pim-1, 2, 3, and FLT3 respectively. After 1 h incubation, reactions were developed and terminated, and fluorescence ratios were calculated following the manufacturer’s protocol.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A